Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 9 ... at worst (SOF) or multiple organ failure (MOF) over 14 days. Twelve patients received immunosuppressive (IS) drugs before sepsis. We measured: 1) monocyte HLA-DR expression (mHLA-DR); 2) ... At the onset of sepsis, an initial low mHLA-DR was not related to any prior IS drug regimen, the severity of the sepsis or the outcome," wrote D. Payen and colleagues. ...
2009 OCT 12 ... of transplant allograft rejection is a major significant segment of the worldwide immunosuppressive market for which sales of Prograf® in 2008 were approximately USD 1.9 billion (IMS; ... study in stable liver transplant patients provide a confirmation of the proposed dosing regimen. With the results announced as well as the results announced in August 2009 from the ...
2009 OCT 12 ... trial to study the effects of withdrawal of cyclosporine A (CsA) from a triple immunosuppressive regimen containing CsA, prednisolone (P), and mycophenolate sodium (MPS) early after ...
2009 NOV 23 ... complications have not been associated with the transplantation procedure, immunosuppressive regimen, tolerance-inducing regimen, or encapsulation of the islets. Pre-clinical trials in ...
2009 NOV 16 ... open-label study evaluated the efficacy and safety of FTY720, as a part of an immunosuppressive regimen, in combination with everolimus and steroids in de novo renal transplant recipients at ...
2009 OCT 19 ... who underwent an orthotopic liver transplantation from cadaveric donors received a basic immunosuppressive regimen containing tacrolimus and corticosteroids; mycophenolate mofetil was added in 18 cases. ...
2009 SEP 28 ... refractory to conventional therapies and mycophenolate mofetil. We initiated combination immunosuppressive therapy with methotrexate sodium and mycophenolate mofetil, which resulted in a safe and ... In our patient, sarcoidal bone marrow involvement responded dramatically to a combined regimen of methotrexate and mycophenolate mofetil with no significant adverse effects, despite ...
2009 NOV 2 ... requires lifelong irnmunosuppression with agents that prevent allograft rejection. Immunosuppressive regimens typically include a steroid, an immune modulator (eg, azathioprine, ... patients and their families about tacrolimus. Patients' adherence to this medication regimen is pivotal for allograft survival. A consistent and comprehensive approach to education ...
2009 NOV 1 ... proliferation, whereas manifestation of apoptotic cell death was not affected by the immunosuppressive treatment regimen. RAPA is capable of inhibiting angiogenesis, microvascular blood ...
2009 NOV 1 ... between cellular and humoral postvaccinal responses. No impact of sex, age or immunosuppressive regimen could be evidenced. Vaccination was not associated with any significant change in ...
2009 SEP 14 ... According to recent research published in the Journal of Immunology, "Immunosuppressive drugs and cytotoxic chemotherapy agents are designed to kill or suppress autoreactive, ... and that mTEC regeneration follows a conserved pattern regardless of the treatment regimen used," wrote A.L. Fletcher and colleagues, Monash University. The ...
2009 OCT 12 ... of a nephrotoxicity- and atherogenicity-free, mycophenolate mofetil (MMF)-based immunosuppressive protocol for elderly recipients of kidneys from elderly cadaveric donors. We ... recipients of kidneys from elderly cadaveric donors. We investigated a therapeutic regimen of strictly monitored MMF (target mycophenolic acid [MPA] trough levels between 2-6 mu ...
2009 OCT 19 ... associated with rituximab therapy in RTx. A total of 83 patients were enrolled. The immunosuppressive regimen consisted of tacrolimus or cyclosporin, mycophenolate mofetil, methylprednisolone and ...
2009 NOV 16 ... the treatment of HCV infection. SCY-635 is the first candidate in a novel class of non-immunosuppressive cyclophilin inhibitors owned by SCYNEXIS. Cyclophilins are a family of enzymatic ... novel cyclophilin inhibitor method-of-action, when used as part of a combination therapy regimen, may help overcome resistance and could also increase the percentage of patients that ...
2009 OCT 12 ... heart transplant units (16) regarding the use/withdrawal of steroids as part of the immunosuppressive maintenance therapy." "We sent an 11-item questionnaire to the clinical ... percentage of cases (<30%), all units had to reintroduce steroids in the maintenance regimen due to an ARE (73%). Most heart transplant units (78.5%) performed SW at 1 year after ...
2009 OCT 12 ... (Advagraf, ADV), mycophenolate mofetil, and low-dose corticosteroids as the initial immunosuppressive regimen. and graft survival, the rates of acute rejection, graft function as well as ADV ...
2009 SEP 14 ... analysis with studies including alemtuzumab induction followed by a tacrolimus-based immunosuppressive regimen showed that the acute rejection rate (ARR) was lower relative to the control (OR=0.59, ...
2009 SEP 14 ... loss and patient death, in particular, in patients who are on sirolimus as part of the immunosuppressive regimen," wrote R.T. Neff and colleagues, Army. The researchers concluded: "The ...
